Skip to main content

Advertisement

SpringerLink
Log in

Worldwide Utilization Patterns of Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction

  • Neurogenic Bladder (C Powell, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

This article reviews the current literature in regard to sacral neuromodulation (SNM) for neurogenic lower urinary tract dysfunction (NLUTD). Studies were identified by electronic search of PubMed database (last search in March 2016) and by screening of reference lists. Most case series have several limitations, including lack of standardized criteria for indications, definition of test phase success, criteria for successful clinical outcomes, and short-term follow-up. Of particular interest is the fact that few series used urodynamics to evaluate the effect of SNM in their patients and not all of them were able to demonstrate significant changes even for patients with clinical improvement. SNM seems to be a promising therapy for the treatment of refractory NLUTD in selected patients, with low reported rates of complications. Further prospective studies with larger sample sizes, appropriate disease classification, standardized definitions of success, and longer follow-up with special attention to failure and complication rates are needed to help define the indications for SNM in patients with NLUTD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Bernstein AJ, Peters KM. Expanding indications for neuromodulation. Urol Clin North Am. 2005;32(1):59–63.

    Article  PubMed  Google Scholar 

  2. Kessler TM, Wöllner J, Kozomara M, Mordasini L, Mehnert U. Urologe A. 2012;51(2):179–83.

    Article  CAS  PubMed  Google Scholar 

  3. Evidence OCfE-bMLo. Centre for evidence-based medicine web site. 2001.

  4. Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010;58(6):865–74.

    Article  PubMed  Google Scholar 

  5. Lansen-Koch SM, Govaert B, Oerlemans D, et al. Sacral nerve modulation for defaecation and micturition disorders in patients with spina bifida. Colorectal Dis. 2012;14(4):508–14.

    Article  CAS  PubMed  Google Scholar 

  6. Groen LA, Hoebeke P, Loret N, et al. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience. J Urol. 2012;188(4):1313–7.

    Article  PubMed  Google Scholar 

  7. Chaabane W, Guillotreau J, Castel-Lacanal E, et al. Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study. Neurourol Urodyn. 2011;30(4):547–50.

    Article  PubMed  Google Scholar 

  8. Engeler DS, Meyer D, Abt D, Müller S, Schmid HP. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol. 2015;15:105. This study described bilateral tined-lead implants for selected patients, which were refractory to unilateral stimulation.

  9. Arlen AM, Powell CR, Kreder KJ. Sacral neuromodulation for refractory urge incontinence is less effective following spinal surgery. ScientificWorldJournal. 2011;11:142–6.

    Article  PubMed  Google Scholar 

  10. Lombardi G, Nelli F, Mencarini M, Del Popolo G. Clinical concomitant benefits on pelvic floor dysfunctions after sacral neuromodulation in patients with incomplete spinal cord injury. Spinal Cord. 2011;49(5):629–36.

    Article  CAS  PubMed  Google Scholar 

  11. Minardi D, Muzzonigro G. Sacral neuromodulation in patients with multiple sclerosis. World J Urol. 2012;30(1):123–8.

    Article  PubMed  Google Scholar 

  12. Peters KM, Kandagatla P, Killinger KA, Wolfert C, Boura JA. Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Urology. 2013;81(4):738–43. SNM complications, revisions/explants, and reprogramming sessions were similar between the patients with or without a neurological disease.

  13. Lombardi G, Musco S, Celso M, et al. Intravesical electrostimulation versus sacral neuromodulation for incomplete spinal cord patients suffering from neurogenic non-obstructive urinary retention. Spinal Cord. 2013;51(7):571–8. All 29 with incomplete SCI and neurogenic NOR who were classified as responsive to intravesical electrostimulation (IVES) were also responsive to SNM test phase.

  14. Andretta E, Simeone C, Ostardo E, Pastorello M, Zuliani C. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction. J Neurol Sci. 2014;347(1–2):257–61.

    Article  PubMed  Google Scholar 

  15. Lombardi G, Musco S, Celso M, Del Corso F, Del Popolo G. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience. Spinal Cord. 2014;52(3):241–5. This retrospective study evaluated the effects of SNM for incomplete SCI patients suffering from chronic NOR. First sensation of bladder filling at baseline represented a statistically significant parameter for the success of the first stage SNM.

  16. Chen G, Liao L. Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease. Spinal Cord. 2014.

  17. Wöllner J, Krebs J, Pannek J. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction. Spinal Cord. 2016;54(2):137–40.

    Article  PubMed  Google Scholar 

  18. Sievert KD, Amend B, Gakis G, et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol. 2010;67(1):74–84.

    Article  PubMed  Google Scholar 

  19. Puccini F, Bhide A, Elneil S, Digesu GA. Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis. Int Urogynecol J. 2016;27(3):347–54.

    Article  PubMed  Google Scholar 

  20. Otto W, Nowrotek A, Burger M, Wieland WF, Rößler W, Denzinger S. Aktuelle Urol. 2012;43(3):162–6.

    Article  CAS  PubMed  Google Scholar 

  21. Marinkovic SP, Gillen LM. Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization. Int Urogynecol J. 2010;21(2):223–8.

    Article  PubMed  Google Scholar 

  22. Wallace PA, Lane FL, Noblett KL. Sacral nerve neuromodulation in patients with underlying neurologic disease. Am J Obstet Gynecol. 2007;197(1):96.e1-5.

    PubMed  Google Scholar 

  23. Okafor H, Gill B, Pizarro-Berdichevsky J, et al. MP17-10 sacral neuromodulation therapy in patients with neurologic lower urinary tract dysfunction—should it remain an off label indication? Analysis of 80 consecutive cases. J Urol. 2016;195((4) Supplement):e188. doi:10.1016/j.juro.2016.02.2678.

    Article  Google Scholar 

  24. Knüpfer SC, Liechti MD, Mordasini L, et al. Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction. BMC Urol. 2014;14:65.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Thompson JH, Sutherland SE, Siegel SW. Sacral neuromodulation: therapy evolution. Indian J Urol. 2010;26(3):379–84.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Joussain C, Denys P. Electrical management of neurogenic lower urinary tract disorders. Ann Phys Rehabil Med. 2015;58(4):245–50.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urology Department, Videourodynamics Unit, Moinhos de Vento Hospital, Rua Tiradentes, 333, Porto Alegre, RS, 90560-030, Brazil

    Marcio Augusto Averbeck

  2. Divisão de Urologia do Hospital das Clínicas da Faculdade de Medicina da USP, Rua Barata Ribeiro, 237, Cj 104-106, Sao Paulo, SP, Brazil

    Cristiano Mendes Gomes

Authors
  1. Marcio Augusto Averbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristiano Mendes Gomes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcio Augusto Averbeck.

Ethics declarations

Conflict of Interest

Dr Averbeck reports grants and personal fees from Medtronic, outside the submitted work.

Dr. Gomes reports grants and personal fees from Astellas, grants and personal fees from Medtronics, outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain studies with human or animal subjects performed by the author.

Additional information

This article is part of the Topical Collection on Neurogenic Bladder

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Averbeck, M.A., Gomes, C.M. Worldwide Utilization Patterns of Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction. Curr Bladder Dysfunct Rep 11, 356–364 (2016). https://doi.org/10.1007/s11884-016-0383-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-016-0383-2

Keywords

Search

Navigation